Data Snapshot: Nov 03, 2026
<$50K

Oct-2026

Sales

Neutral

Trend

6-Month

4

Product Count

SKUs

$35.43

Avg Price

30.1%

YoY Sales Change

3.1%

YoY Price Change

C Minor is a highly regarded brand within the cannabis industry, offering a variety of products and related services. Their unique cultivation approach includes licensing options ranging from 'Specialty Cottage' to 'Large', to cater to various market demands, as well as a dedicated nursery for the growth of clones, immature plants, seeds, or other varieties of cannabis. Significantly conscious of user safety and legal stipulations, the company remains fully compliant with Illinois State laws and provides customers with detailed nutritional information for every edible cannabis product, along with careful pharmacological evaluations of minor cannabinoids.
How loyal are cannabis customers to the brands they buy? See retention benchmarks by category and state →
For brands

Is this your brand?

See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.

See your brand's data
For retailers

Carry this brand in your store?

Headset Retailer is free. Connect your POS and see what's selling and what's sitting.

Sign up free
C Minor Sales

Market Insights Snapshot

C Minor Historical Sales by Category

C Minor concentrated 68.48% of October 2026 sales in Capsules and 31.52% in Oil, while Capsules rose 51.95% month over month and 4.86% year over year as Oil climbed 32.05% MoM and 172.38% YoY. Average price increased 3.06% YoY to $35.43, with Capsules priced at $34.67 and Oil at $37.18, and overall brand sales advanced 30.08% YoY despite a 24‑month decline of 26.08%. The mix shift paired with outsized Oil growth and a stable Capsules base implies C Minor is pivoting toward higher-velocity formats without abandoning its core, setting up a two-pronged volume path rather than single-category dependency.

Within Capsules in Ontario, C Minor held rank 12 while Capsules carried 68.48% share of the brand mix and posted a 51.95% MoM lift versus Oil’s 32.05% MoM, indicating the brand can leverage incumbency where it already ranks while Oil’s 172.38% YoY surge expands reach into adjacent need-states. With Oil priced 7.3% above Capsules ($37.18 vs. $34.67) and the overall 3.06% price uptick, the brand’s positioning leans toward accessible premium: Capsules sustains shelf presence and rank, while Oil’s rapid YoY gains signal a margin-accretive extension that can improve pricing power without eroding the Capsules base.

Oct-2026 Rank
Capsules
Oil
#12
#14
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
68.5%
$34.67
+4.9%
+52.0%
Oil
31.5%
$37.18
+172.4%
+32.0%
C Minor

Competitive Landscape

C Minor sits at #12 in ON Capsules in October 2026, unchanged YoY from #12 and flat versus three months ago at #12, while the brand’s peak was #10 in November 2025, a two-rank slide from that high; in contrast, Glacial Gold advanced from #4 to #2 alongside a 75.48% YoY sales gain and Aspire held #1 with 21.82% YoY growth, whereas Redecan fell from #2 to #5 with a -13.59% YoY decline. This combination of zero rank movement YoY and a two-position gap from the November 2025 peak implies C Minor is in a stable but non-advancing tier, and the trajectory suggests that without mix or distribution shifts to dislodge peers who are climbing, the brand risks being bracketed by faster risers and declining incumbents.

C Minor category ranking vs. nearest competitors
C Minor

Notable Products

C Minor’s October 2026 sales are concentrated in one format: Capsules account for 68.5% via CBD Fast Acting 50 Max Softgels 30-Pack, with the remaining 31.5% in Oils. That split means most of the brand’s revenue comes from a single capsule product rather than its three oil SKUs.

Product
Type
Share of Sales
Avg Price
vs. Peer Avg
MoM %
CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD)
CBD / CBN
68.5%
$34.67
—
+52.0%
CBD Isolate 100 Max 3000 Oil (30ml)
CBD
15.5%
$53.03
+55.6%
+24.3%
CBD 50 Max 3000 Oil Drops (60ml)
CBD
9.0%
$30.81
-18.2%
-11.5%
CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml)
CBD
7.1%
$26.76
-21.5%
+447.1%

Peer avg: average price of the same product type and package size in the same states that month.

View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market